Zobrazeno 1 - 6
of 6
pro vyhledávání: '"stavudine DEXA"'
Autor:
Venter, Willem Daniel Francois, Kambugu, Andrew, Chersich, Matthew F, Becker, Stephen, Hill, Andrew, Arulappan, Natasha, Moorhouse, Michelle, Majam, Mohammed, Akpomiemie, Godspower, Sokhela, Simiso, Poongulali, Selvamuthu, Feldman, Charles, Duncombe, Chris, Ripin, David H Brown, Vos, Alinda, Kumarasamy, Nagalingeswaran
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes, 80(2), 224. Lippincott Williams and Wilkins
Background:Reducing doses of antiretroviral drugs, including stavudine (d4T), may lower toxicity, while preserving efficacy. There are substantial concerns about renal and bone toxicities of tenofovir disoproxil fumarate (TDF).Setting:HIV-1-infected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f3fe52d807512b457bb6a261f9a4951b
https://dspace.library.uu.nl/handle/1874/388745
https://dspace.library.uu.nl/handle/1874/388745
Autor:
Willem Daniel Francois, Venter, Andrew, Kambugu, Matthew F, Chersich, Stephen, Becker, Andrew, Hill, Natasha, Arulappan, Michelle, Moorhouse, Mohammed, Majam, Godspower, Akpomiemie, Simiso, Sokhela, Selvamuthu, Poongulali, Charles, Feldman, Chris, Duncombe, David H Brown, Ripin, Alinda, Vos, Nagalingeswaran, Kumarasamy
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes (1999)
Supplemental Digital Content is Available in the Text.
Background: Reducing doses of antiretroviral drugs, including stavudine (d4T), may lower toxicity, while preserving efficacy. There are substantial concerns about renal and bone toxicities o
Background: Reducing doses of antiretroviral drugs, including stavudine (d4T), may lower toxicity, while preserving efficacy. There are substantial concerns about renal and bone toxicities o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c5694fe74c2b58181630409cbf91ea76
https://pubmed.ncbi.nlm.nih.gov/30640204
https://pubmed.ncbi.nlm.nih.gov/30640204
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes. 80(2):224
Background:Reducing doses of antiretroviral drugs, including stavudine (d4T), may lower toxicity, while preserving efficacy. There are substantial concerns about renal and bone toxicities of tenofovir disoproxil fumarate (TDF).Setting:HIV-1-infected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::b843869ebb9d0b765d906bf50ffc6e03
https://hdl.handle.net/1874/388745
https://hdl.handle.net/1874/388745
Autor:
Tungsiripat, Marisa, McComsey, Grace
Publikováno v:
Current HIV/AIDS Reports; May2008, Vol. 5 Issue 2, p55-63, 9p
Autor:
Josep M. Llibre, Pilar Barrufet, Juan D. Pedreira, Juan Berenguer, Rafael Rubio, José Sanz, Esperanza Merino, Miquel Aranda, Luis Del Rio, Ana Lerida, Daniel Podzamczer, Montse Loncá, Pochita Sanchez, J Martínez-Lacasa, Cesar Fisac, Jordi Niubó, José M. Gatell, Manel Crespo, Esteban Ribera, S. Veloso, Antonio Delegido, Maria Angels Ribas, Carlos Alonso, Elena Ferrer, Federico Pulido
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 44:139-147
Objective: To assess lipoatrophy, other toxicities, and efficacy associated with abacavir as compared with stavudine in HIV-infected antiretroviral-naive patients. Methods: This was a prospective, randomized, open trial, stratified by viral load and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b571e2246a50fdaabb7c808723924446
https://doi.org/10.1097/qai.0b013e31802bf122
https://doi.org/10.1097/qai.0b013e31802bf122
Autor:
Podzamczer D; Infectious Disease Service, Hospital Universitari de Bellvitge, Barcelona, Spain. dpodzamczer@csub.scs.es, Ferrer E, Sanchez P, Gatell JM, Crespo M, Fisac C, Lonca M, Sanz J, Niubo J, Veloso S, Llibre JM, Barrufet P, Ribas MA, Merino E, Ribera E, Martínez-Lacasa J, Alonso C, Aranda M, Pulido F, Berenguer J, Delegido A, Pedreira JD, Lérida A, Rubio R, del Río L
Publikováno v:
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2007 Feb 01; Vol. 44 (2), pp. 139-47.